Fas/FasL interaction: A novel immune the
โ
Martin Scholz; Jindrich Cinatl
๐
Article
๐
2005
๐
John Wiley and Sons
๐
English
โ 322 KB
Systemically applied agents to modulate the Fas/FasL system, e.g., by stimulation of Fas on activated leukocytes or tumor cells failed as strategies in immune therapy due to severe toxic effects in the host. Recently, a novel strategy has been developed by using immobilized immune active biologicals